MADISON EDWIN L.,MADISON Edwin L.,NGUYEN JACK,NGUYEN Jack,RUGGLES SANDRA WAUGH,RUGGLES Sandra Waugh,THANOS CHRISTOPHER D.,THANOS Christopher D.
申请号：
SI200631548
公开号：
SI1940457T1
申请日:
2006.10.20
申请国别(地区):
SI
年份:
2013
代理人:
摘要：
Provided are methods for and compounds for modulating the complement system. In particular, compounds are provided that inhibit complement activation and compounds are provided that promote complement activation. The compounds are therapeutics by virtue of their effects on the complement system. Hence, the compounds that inhibit complement activation can be used for treatment of ischemic and reperfusion disorders, including myocardial infarction and stroke, sepsis, autoimmune diseases, inflammatory diseases and diseases with an inflammatory component, including Alzheimers Disease and other neurodegenerative disorder.
